Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar 23;107(12):5540-4.
doi: 10.1073/pnas.0912675107. Epub 2010 Mar 8.

Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis

Affiliations

Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis

Wook-Jin Chae et al. Proc Natl Acad Sci U S A. .

Abstract

The intrinsic role of endogenous IL-17A in spontaneous intestinal tumorigenesis has not been addressed previously to our knowledge. Ablation of IL-17A significantly reduced tumor development in mice bearing a heterozygote mutation in the adenomatous polyposis coli (APC) gene (Apc(Min/+) mice). There was also a decrease in inflammatory cytokines and proinflammatory mediators, reduced infiltration of lymphocytes including T cells, and preservation of intestinal architecture and the presence of APC protein in intestinal epithelial cells. Interestingly, IL-17A ablation also corrected immunological abnormalities such as splenomegaly and thymic atrophy in Apc(Min/+) mice. CD4 T cells from Apc(Min/+) mice showed hyperproliferative potential in vitro and in vivo and increased levels of IL-17A and IL-10. The effector CD4 T cells from Apc(Min/+) mice were more resistant to regulatory T cell-mediated suppression. Finally, these CD4 T cells induced colitis in immunodeficient mice upon adoptive transfer, whereas the ablation of IL-17A in CD4 T cells in Apc(Min/+) mice completely abolished this pathogenic potential in vivo. Taken together, our results show that CD4 T cell-derived IL-17A promotes spontaneous intestinal tumorigenesis with altered functions of CD4 T cells in Apc(Min/+) mice.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1.
Fig. 1.
IL-17A ablation significantly reduces intestinal tumorigenesis. (A) Tumor numbers of small and large intestine were counted in 20-week-old ApcMin/+ mice (n = 16) and IL-17A KO- ApcMin/+ mice (n = 13). (B) Tumors smaller than 3 mm and larger than 3 mm were counted separately. (C) Tumor numbers from each part of small intestine (duodenum, jejunum, and ileum). For both comparisons, *P < 0.002 using two-tailed t tests.
Fig. 2.
Fig. 2.
Ablation of IL-17A preserved small intestinal architecture in ApcMin/+ mice and reduces immune cell infiltration. Small intestines (ileum) of 20-week-old C57BL/6 (n = 5), ApcMin/+ (n = 4), and IL-17A KO- ApcMin/+ (n = 4) mice were harvested and stained with H&E (A) and murine anti-CD3 monoclonal antibody (B). Ileums of same group of mice were stained with anti-APC monoclonal antibody (C) with paraffin-embedded section.
Fig. 3.
Fig. 3.
IL-17A ablation reduced proinflammatory cytokines and mediators in tumors. Tumors (3 mm; one or two from each mouse) were dissected from 20-week-old ApcMin/+ mice (n = 5) and IL-17A KO- ApcMin/+ mice (n = 4). mRNA level was normalized against HPRT. For WT C57BL/6 mice, 5 mm of ileum was used. Values are means ± SD of all experiments.
Fig. 4.
Fig. 4.
Splenomegaly and thymic atrophy of ApcMin/+ mice are corrected by IL-17A ablation. Spleens and thymuses from 20-week-old ApcMin/+ and IL-17A KO ApcMin/+ mice and littermate controls of ApcMin/+ were dissected (A) and counted for cell numbers (B), and subsequently analyzed by flow cytometry (C). Flow cytometry is a representative of five mice per group. *P ≤ 0.002; one-way analysis was used with Tukey correction at an α of 0.05.
Fig. 5.
Fig. 5.
CD4 T cells from ApcMin/+ mice are functionally altered. (A) CD4 T cells from ApcMin/+ mice were isolated and activated with given amount of anti-CD3 and T cell–depleted irradiated splenocytes for 72 h. (B) Foxp3+ regulatory T cells were isolated from ApcMin/+ Foxp3-IRES-RFP mice and cocultured with Foxp3- CD4 effector T cells from either ApcMin/+ mice or their littermate control for 72 h for given ratios. (C) CD4 T cells from ApcMin/+ mice were isolated and activated for 96 h, and cytokines were measured by cytokine bead array. Data indicate means ± SD of three separate experiments as triplicates.
Fig. 6.
Fig. 6.
Ablation of IL-17A in CD4 T cells corrects altered functions in CD4 T cells from ApcMin/+ mice. (A) CD4 T cells from 11-week-old ApcMin/+ and IL-17A KO ApcMin/+ mice and littermate controls ApcMin/+ mice were isolated and transferred into Rag 2 KO mice. After 4 weeks of transfer, spleens were harvested and cell numbers were counted, and the ratio between CD4 effector T cells and Foxp3+ CD4 T cells was measured by flow cytometry (B). Colons were harvested and scored for their chronicity (C) and stained with H&E (D). The experiments are the representative of two independent experiments.

References

    1. Dubin PJ, Kolls JK. Th17 cytokines and mucosal immunity. Immunol Rev. 2008;226:160–171. - PubMed
    1. Ogura H, et al. Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction. Immunity. 2008;29:628–636. - PubMed
    1. Abraham C, Cho J. Interleukin-23/Th17 pathways and inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:1090–1100. - PubMed
    1. Atarashi K, et al. ATP drives lamina propria T(H)17 cell differentiation. Nature. 2008;455:808–812. - PubMed
    1. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol. 2009;27:485–517. - PubMed

Publication types

MeSH terms

LinkOut - more resources